Inspira Technologies Partners with Westchester Medical Center to Advance Patient Care with ART100 Evaluation
Inspira Technologies OXY B.H.N. Ltd., listed on NASDAQ under the tickers IINN and IINNW, has announced a strategic collaboration with Westchester Medical Center, located in Valhalla, New York. This partnership aims to assess the effectiveness and performance of the innovative INSPIRA ART100 systems in real-world clinical settings. The collaboration will provide leading medical professionals and institutions the opportunity to experience inspiring health care technologies that promise to revolutionize patient treatment.
Westchester Medical Center is renowned for its advanced medical services and will be at the forefront of evaluating the INSPIRA ART100 systems. As part of this collaboration, there exists a mutual goal of exploring long-term partnerships, particularly for future technologies like the next-generation INSPIRA ART system, which is designed to treat acute respiratory failure by quickly elevating declining oxygen saturation levels without the reliance on mechanical ventilators. This innovative approach could significantly improve outcomes for patients battling respiratory issues.
Joe Hayon, co-founder and President of Inspira Technologies, expressed excitement about this collaboration, stating that supplying Westchester Medical Center with FDA-cleared devices reflects the rising interest and demand for their advanced technologies. Meanwhile, the medical center's leadership, typified by Dr. David Spielvogel, the Section Chief of Cardiothoracic Surgery, emphasizes Westchester's commitment to investing in advanced technologies that enhance the treatment quality and effectiveness for patients facing acute respiratory complications.
The INSPIRA ART100 system has already received FDA 510(k) clearance for use during Cardiopulmonary Bypass surgeries, positioning it as a state-of-the-art solution in critical care environments. Furthermore, Inspira Technologies has developed the Augmented Respiration Technology, which is set to transform the medical treatment of respiratory failure—a condition affecting millions of ICU patients each year.
This collaboration with Westchester Medical Center signifies a pivotal step in bringing novel medical technologies to bear on patient care challenges such as respiratory failure. The tightly knit team at Inspira Technologies is focused on not only innovating but also ensuring that these innovations translate into practical, real-world applications that enhance the quality of life for patients. As such, the partnership will also incorporate feedback and results from medical professionals at Westchester to refine and improve the ART100 system further.
As a participant in this important initiative, Westchester Medical Center, with its 1,700+ bed healthcare system, is poised to leverage Inspira’s innovations effectively. Located in the Hudson Valley, it serves as a key healthcare provider within the region, specializing in advanced medical care, including Cardiopulmonary Bypass and Extracorporeal Membrane Oxygenation (ECMO) procedures. This strategic partnership reinforces Westchester’s vision of investing in innovative technologies that provide the safest and most effective patient care available.
Inspira Technologies, too, stands at the cutting edge of medical innovations. With their proprietary systems designed specifically for respiratory care, they are moving towards making significant inroads in a market valued at over $19 billion. The goal is to offer practical alternatives to invasive mechanical ventilation while keeping patients alert and engaged during treatment.
In closing, the collaboration between Inspira Technologies and Westchester Medical Center marks an important milestone in the medical field, where innovative technology and healthcare come together to improve patient outcomes drastically. As they move forward, both companies hope to enhance treatment methods and set new standards for acute respiratory care, opening doors to further advancements in medical technology and patient care globally.
Westchester Medical Center is renowned for its advanced medical services and will be at the forefront of evaluating the INSPIRA ART100 systems. As part of this collaboration, there exists a mutual goal of exploring long-term partnerships, particularly for future technologies like the next-generation INSPIRA ART system, which is designed to treat acute respiratory failure by quickly elevating declining oxygen saturation levels without the reliance on mechanical ventilators. This innovative approach could significantly improve outcomes for patients battling respiratory issues.
Joe Hayon, co-founder and President of Inspira Technologies, expressed excitement about this collaboration, stating that supplying Westchester Medical Center with FDA-cleared devices reflects the rising interest and demand for their advanced technologies. Meanwhile, the medical center's leadership, typified by Dr. David Spielvogel, the Section Chief of Cardiothoracic Surgery, emphasizes Westchester's commitment to investing in advanced technologies that enhance the treatment quality and effectiveness for patients facing acute respiratory complications.
The INSPIRA ART100 system has already received FDA 510(k) clearance for use during Cardiopulmonary Bypass surgeries, positioning it as a state-of-the-art solution in critical care environments. Furthermore, Inspira Technologies has developed the Augmented Respiration Technology, which is set to transform the medical treatment of respiratory failure—a condition affecting millions of ICU patients each year.
This collaboration with Westchester Medical Center signifies a pivotal step in bringing novel medical technologies to bear on patient care challenges such as respiratory failure. The tightly knit team at Inspira Technologies is focused on not only innovating but also ensuring that these innovations translate into practical, real-world applications that enhance the quality of life for patients. As such, the partnership will also incorporate feedback and results from medical professionals at Westchester to refine and improve the ART100 system further.
As a participant in this important initiative, Westchester Medical Center, with its 1,700+ bed healthcare system, is poised to leverage Inspira’s innovations effectively. Located in the Hudson Valley, it serves as a key healthcare provider within the region, specializing in advanced medical care, including Cardiopulmonary Bypass and Extracorporeal Membrane Oxygenation (ECMO) procedures. This strategic partnership reinforces Westchester’s vision of investing in innovative technologies that provide the safest and most effective patient care available.
Inspira Technologies, too, stands at the cutting edge of medical innovations. With their proprietary systems designed specifically for respiratory care, they are moving towards making significant inroads in a market valued at over $19 billion. The goal is to offer practical alternatives to invasive mechanical ventilation while keeping patients alert and engaged during treatment.
In closing, the collaboration between Inspira Technologies and Westchester Medical Center marks an important milestone in the medical field, where innovative technology and healthcare come together to improve patient outcomes drastically. As they move forward, both companies hope to enhance treatment methods and set new standards for acute respiratory care, opening doors to further advancements in medical technology and patient care globally.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.